Cargando…
Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
Nanotechnology has become a powerful approach to improve the way we diagnose and treat cancer. In particular, nanoparticles (NPs) possess unique features for enhanced sensitivity and selectivity for earlier detection of circulating cancer biomarkers. In vivo, NPs enhance the therapeutic efficacy of...
Autores principales: | Vinhas, Raquel, Mendes, Rita, Fernandes, Alexandra R., Baptista, Pedro V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741836/ https://www.ncbi.nlm.nih.gov/pubmed/29326927 http://dx.doi.org/10.3389/fbioe.2017.00079 |
Ejemplares similares
-
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
por: Vinhas, Raquel, et al.
Publicado: (2017) -
Nanotheranostics Targeting the Tumor Microenvironment
por: Roma-Rodrigues, Catarina, et al.
Publicado: (2019) -
Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021) -
Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
por: Wang, Rui, et al.
Publicado: (2022) -
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020)